

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.69478115 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.46512088 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27222970 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.27222970 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 7.22716649 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 7.11942697 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 7.11942697 |
| 8 | tryptophan catabolic process (GO:0006569) | 7.11942697 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 7.11477823 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11477823 |
| 11 | fibrinolysis (GO:0042730) | 7.00685092 |
| 12 | lysine catabolic process (GO:0006554) | 6.99096733 |
| 13 | lysine metabolic process (GO:0006553) | 6.99096733 |
| 14 | cysteine metabolic process (GO:0006534) | 6.80254439 |
| 15 | kynurenine metabolic process (GO:0070189) | 6.80075930 |
| 16 | glyoxylate metabolic process (GO:0046487) | 6.64829231 |
| 17 | tryptophan metabolic process (GO:0006568) | 6.62702542 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 6.26178332 |
| 19 | urate metabolic process (GO:0046415) | 6.08616847 |
| 20 | drug transmembrane transport (GO:0006855) | 5.94818665 |
| 21 | oxidative demethylation (GO:0070989) | 5.89567010 |
| 22 | drug metabolic process (GO:0017144) | 5.86461904 |
| 23 | regulation of plasminogen activation (GO:0010755) | 5.66600452 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.60863959 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 5.56393551 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.48884334 |
| 27 | phospholipid efflux (GO:0033700) | 5.36862783 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.35358712 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 5.27729498 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.26408241 |
| 31 | negative regulation of blood coagulation (GO:0030195) | 5.15582004 |
| 32 | negative regulation of hemostasis (GO:1900047) | 5.15582004 |
| 33 | homocysteine metabolic process (GO:0050667) | 5.14391922 |
| 34 | drug transport (GO:0015893) | 5.06250136 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 5.02897773 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 5.02217010 |
| 37 | indolalkylamine metabolic process (GO:0006586) | 4.98951601 |
| 38 | glutamate metabolic process (GO:0006536) | 4.94669679 |
| 39 | protein activation cascade (GO:0072376) | 4.92266707 |
| 40 | aspartate family amino acid catabolic process (GO:0009068) | 4.86809194 |
| 41 | serine family amino acid metabolic process (GO:0009069) | 4.83457634 |
| 42 | cellular biogenic amine catabolic process (GO:0042402) | 4.83142840 |
| 43 | amine catabolic process (GO:0009310) | 4.83142840 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.81058208 |
| 45 | ethanol metabolic process (GO:0006067) | 4.78968318 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 4.74944035 |
| 47 | urea metabolic process (GO:0019627) | 4.71311192 |
| 48 | urea cycle (GO:0000050) | 4.71311192 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 4.70153979 |
| 50 | negative regulation of coagulation (GO:0050819) | 4.68790258 |
| 51 | alpha-linolenic acid metabolic process (GO:0036109) | 4.68633621 |
| 52 | bile acid metabolic process (GO:0008206) | 4.65624778 |
| 53 | negative regulation of wound healing (GO:0061045) | 4.63068037 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.60212033 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.60186246 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.60186246 |
| 57 | positive regulation of hemostasis (GO:1900048) | 4.58832061 |
| 58 | positive regulation of blood coagulation (GO:0030194) | 4.58832061 |
| 59 | alkaloid metabolic process (GO:0009820) | 4.58389726 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 4.57382152 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.56891562 |
| 62 | cholesterol efflux (GO:0033344) | 4.56598469 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 4.51687254 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 4.51090529 |
| 65 | regulation of humoral immune response (GO:0002920) | 4.46225341 |
| 66 | acute-phase response (GO:0006953) | 4.46106248 |
| 67 | complement activation, alternative pathway (GO:0006957) | 4.46022033 |
| 68 | complement activation, classical pathway (GO:0006958) | 4.45774009 |
| 69 | complement activation (GO:0006956) | 4.45501391 |
| 70 | serine family amino acid biosynthetic process (GO:0009070) | 4.44647095 |
| 71 | nitrogen cycle metabolic process (GO:0071941) | 4.40668700 |
| 72 | tyrosine metabolic process (GO:0006570) | 4.36762678 |
| 73 | ketone body metabolic process (GO:1902224) | 4.34795608 |
| 74 | regulation of protein activation cascade (GO:2000257) | 4.34688022 |
| 75 | protein carboxylation (GO:0018214) | 4.34619327 |
| 76 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.34619327 |
| 77 | negative regulation of lipase activity (GO:0060192) | 4.31495428 |
| 78 | drug catabolic process (GO:0042737) | 4.30399316 |
| 79 | negative regulation of fibrinolysis (GO:0051918) | 4.30327116 |
| 80 | organic cation transport (GO:0015695) | 4.25414509 |
| 81 | positive regulation of coagulation (GO:0050820) | 4.22474105 |
| 82 | response to mercury ion (GO:0046689) | 4.20581349 |
| 83 | coenzyme catabolic process (GO:0009109) | 4.19571158 |
| 84 | S-adenosylmethionine metabolic process (GO:0046500) | 4.18768815 |
| 85 | valine metabolic process (GO:0006573) | 4.15651053 |
| 86 | regulation of fibrinolysis (GO:0051917) | 4.13909776 |
| 87 | negative regulation of protein activation cascade (GO:2000258) | 4.12698466 |
| 88 | regulation of complement activation (GO:0030449) | 4.10616111 |
| 89 | glycine metabolic process (GO:0006544) | 4.10033466 |
| 90 | regulation of lipoprotein particle clearance (GO:0010984) | 4.01608084 |
| 91 | high-density lipoprotein particle remodeling (GO:0034375) | 4.01314247 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 4.00981148 |
| 93 | organic acid catabolic process (GO:0016054) | 4.00981148 |
| 94 | hormone catabolic process (GO:0042447) | 3.99711395 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.99082978 |
| 96 | fatty acid oxidation (GO:0019395) | 3.98768495 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98400063 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.96926892 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.96474438 |
| 100 | carnitine metabolic process (GO:0009437) | 3.94040670 |
| 101 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.91559071 |
| 102 | ethanol oxidation (GO:0006069) | 3.91481041 |
| 103 | lipid oxidation (GO:0034440) | 3.91142110 |
| 104 | heme transport (GO:0015886) | 3.91138478 |
| 105 | intestinal cholesterol absorption (GO:0030299) | 3.90765808 |
| 106 | cellular glucuronidation (GO:0052695) | 3.89723713 |
| 107 | plasma lipoprotein particle clearance (GO:0034381) | 3.87892303 |
| 108 | negative regulation of sterol transport (GO:0032372) | 3.87225430 |
| 109 | negative regulation of cholesterol transport (GO:0032375) | 3.87225430 |
| 110 | branched-chain amino acid metabolic process (GO:0009081) | 3.86693172 |
| 111 | phosphate ion transport (GO:0006817) | 3.84711068 |
| 112 | phosphate ion transmembrane transport (GO:0035435) | 3.81503617 |
| 113 | indole-containing compound metabolic process (GO:0042430) | 3.76355492 |
| 114 | bile acid and bile salt transport (GO:0015721) | 3.75994970 |
| 115 | regulation of triglyceride catabolic process (GO:0010896) | 3.74261581 |
| 116 | acylglycerol homeostasis (GO:0055090) | 3.73664129 |
| 117 | triglyceride homeostasis (GO:0070328) | 3.73664129 |
| 118 | cytolysis (GO:0019835) | 3.71500740 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.69712191 |
| 120 | fatty acid catabolic process (GO:0009062) | 3.68511236 |
| 121 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.66467610 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.66075060 |
| 123 | branched-chain amino acid catabolic process (GO:0009083) | 3.64610544 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.62679740 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.62679740 |
| 126 | opsonization (GO:0008228) | 3.60214039 |
| 127 | arginine metabolic process (GO:0006525) | 3.59735920 |
| 128 | steroid catabolic process (GO:0006706) | 3.58178830 |
| 129 | fructose metabolic process (GO:0006000) | 3.58101333 |
| 130 | flavonoid metabolic process (GO:0009812) | 3.57895651 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.50899578 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.50817706 |
| 133 | acute inflammatory response (GO:0002526) | 3.50667602 |
| 134 | reverse cholesterol transport (GO:0043691) | 3.48438609 |
| 135 | imidazole-containing compound metabolic process (GO:0052803) | 3.47275335 |
| 136 | negative regulation of complement activation (GO:0045916) | 3.46503544 |
| 137 | regulation of cholesterol esterification (GO:0010872) | 3.46417356 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 3.46106799 |
| 139 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45967214 |
| 140 | protein-lipid complex remodeling (GO:0034368) | 3.45967214 |
| 141 | macromolecular complex remodeling (GO:0034367) | 3.45967214 |
| 142 | dicarboxylic acid metabolic process (GO:0043648) | 3.44215615 |
| 143 | negative regulation of lipid transport (GO:0032369) | 3.42188861 |
| 144 | small molecule catabolic process (GO:0044282) | 3.41434941 |
| 145 | tricarboxylic acid metabolic process (GO:0072350) | 3.40449233 |
| 146 | response to nitrosative stress (GO:0051409) | 3.40378024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.08998858 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.96611099 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.24422892 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16795383 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16690201 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71082060 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37417065 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83161954 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.73698663 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44926022 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35507121 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13049050 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2857040 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68348623 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66145457 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61115702 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53458501 |
| 18 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37701892 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36051142 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34710861 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.34026453 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32159340 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24187569 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23270064 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16419766 |
| 26 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16234775 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13893187 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13775759 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13206873 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05208331 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02519489 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01404952 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00920414 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99985461 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98611713 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96857968 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91622021 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88235388 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84044885 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83740351 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82220642 |
| 42 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80625878 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80103309 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79022272 |
| 45 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77946366 |
| 46 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77391009 |
| 47 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77091980 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76621483 |
| 49 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.73572200 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73204801 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73064820 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72451107 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.71824493 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71636088 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70707187 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.69436756 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68891396 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68152768 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67889423 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67561430 |
| 61 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.67411477 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.66797810 |
| 63 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.66552913 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66302210 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65895876 |
| 66 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.65705857 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.65592715 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65332656 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65332656 |
| 70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65248082 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.64852862 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64338455 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63980248 |
| 74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63063630 |
| 75 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.62727796 |
| 76 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.62433753 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61933658 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61835145 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.60164103 |
| 80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60147011 |
| 81 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59978569 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.59650857 |
| 83 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58996303 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58944246 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.58724007 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58683138 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.57471398 |
| 88 | NFYA_21822215_ChIP-Seq_K562_Human | 0.57310499 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56934593 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55606834 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55416784 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.55111462 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.55099328 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55071285 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.54081508 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.53491891 |
| 97 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53396700 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53083138 |
| 99 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.52883779 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52586022 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.52263426 |
| 102 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.51923007 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 0.51335112 |
| 104 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.51109635 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.50698384 |
| 106 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.50594176 |
| 107 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50537034 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.50327094 |
| 109 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.50110894 |
| 110 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.49617502 |
| 111 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49612707 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48856729 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.48633940 |
| 114 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.48563634 |
| 115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47614874 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.47534853 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47419208 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47221255 |
| 119 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.47078033 |
| 120 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.46783624 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45990377 |
| 122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.45773626 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45693274 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45259147 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44997257 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44517151 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44296004 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44295422 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44285763 |
| 130 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44285763 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43733600 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.42516485 |
| 133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41475370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.68171510 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.81836966 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.53205565 |
| 4 | MP0005365_abnormal_bile_salt | 5.36417988 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63252556 |
| 6 | MP0005332_abnormal_amino_acid | 3.85535841 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.80606303 |
| 8 | MP0003195_calcinosis | 3.68742228 |
| 9 | MP0003252_abnormal_bile_duct | 3.61666118 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.21373802 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.91218798 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.74791215 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.42952554 |
| 14 | MP0009840_abnormal_foam_cell | 2.32198788 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.29724788 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.29529434 |
| 17 | MP0005083_abnormal_biliary_tract | 2.24666485 |
| 18 | MP0004043_abnormal_pH_regulation | 2.24525925 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.84511340 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83867339 |
| 21 | MP0000609_abnormal_liver_physiology | 1.80205812 |
| 22 | MP0005636_abnormal_mineral_homeostasis | 1.73531148 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.70177339 |
| 24 | MP0001764_abnormal_homeostasis | 1.62661085 |
| 25 | MP0001756_abnormal_urination | 1.59712252 |
| 26 | MP0003868_abnormal_feces_composition | 1.55141265 |
| 27 | MP0003186_abnormal_redox_activity | 1.47059593 |
| 28 | MP0001765_abnormal_ion_homeostasis | 1.34364677 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.33145095 |
| 30 | MP0002136_abnormal_kidney_physiology | 1.32573317 |
| 31 | MP0005451_abnormal_body_composition | 1.32353895 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.02600967 |
| 33 | MP0000598_abnormal_liver_morphology | 1.01824197 |
| 34 | MP0005084_abnormal_gallbladder_morpholo | 1.00429937 |
| 35 | MP0005647_abnormal_sex_gland | 0.96274016 |
| 36 | MP0009764_decreased_sensitivity_to | 0.96016147 |
| 37 | MP0002132_abnormal_respiratory_system | 0.95461101 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 0.94150397 |
| 39 | MP0005535_abnormal_body_temperature | 0.92646381 |
| 40 | MP0001661_extended_life_span | 0.90264001 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.89339952 |
| 42 | MP0000604_amyloidosis | 0.87659641 |
| 43 | MP0005670_abnormal_white_adipose | 0.86628239 |
| 44 | MP0001915_intracranial_hemorrhage | 0.86382000 |
| 45 | MP0008469_abnormal_protein_level | 0.85463696 |
| 46 | MP0005058_abnormal_lysosome_morphology | 0.82790244 |
| 47 | MP0000538_abnormal_urinary_bladder | 0.80726065 |
| 48 | MP0009697_abnormal_copulation | 0.78937922 |
| 49 | MP0005187_abnormal_penis_morphology | 0.78348520 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 0.77293798 |
| 51 | MP0003011_delayed_dark_adaptation | 0.76718492 |
| 52 | MP0002928_abnormal_bile_duct | 0.76128471 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 0.74922728 |
| 54 | MP0009763_increased_sensitivity_to | 0.72592853 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.72335888 |
| 56 | MP0003879_abnormal_hair_cell | 0.70163049 |
| 57 | MP0002254_reproductive_system_inflammat | 0.69927799 |
| 58 | MP0005408_hypopigmentation | 0.69620664 |
| 59 | MP0005376_homeostasis/metabolism_phenot | 0.68421051 |
| 60 | MP0003638_abnormal_response/metabolism_ | 0.68129322 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.67636345 |
| 62 | MP0005464_abnormal_platelet_physiology | 0.63885989 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.63713105 |
| 64 | MP0003329_amyloid_beta_deposits | 0.63189191 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.63090650 |
| 66 | MP0005395_other_phenotype | 0.63037810 |
| 67 | MP0002282_abnormal_trachea_morphology | 0.62962101 |
| 68 | MP0002168_other_aberrant_phenotype | 0.62379648 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.62210412 |
| 70 | MP0003878_abnormal_ear_physiology | 0.60724274 |
| 71 | MP0005377_hearing/vestibular/ear_phenot | 0.60724274 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.56984275 |
| 73 | MP0002796_impaired_skin_barrier | 0.56013779 |
| 74 | MP0002135_abnormal_kidney_morphology | 0.55720431 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.53974231 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 0.53866637 |
| 77 | MP0002971_abnormal_brown_adipose | 0.53629962 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.53531413 |
| 79 | MP0005334_abnormal_fat_pad | 0.51813610 |
| 80 | MP0005266_abnormal_metabolism | 0.51799157 |
| 81 | MP0003690_abnormal_glial_cell | 0.50052889 |
| 82 | MP0004883_abnormal_blood_vessel | 0.48144862 |
| 83 | MP0003959_abnormal_lean_body | 0.46094076 |
| 84 | MP0003724_increased_susceptibility_to | 0.45447633 |
| 85 | MP0009053_abnormal_anal_canal | 0.44968637 |
| 86 | MP0005164_abnormal_response_to | 0.44741707 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.43917400 |
| 88 | MP0004130_abnormal_muscle_cell | 0.43436465 |
| 89 | MP0003953_abnormal_hormone_level | 0.42999480 |
| 90 | MP0000249_abnormal_blood_vessel | 0.42867908 |
| 91 | MP0005023_abnormal_wound_healing | 0.42608627 |
| 92 | MP0001958_emphysema | 0.42494815 |
| 93 | MP0009785_altered_susceptibility_to | 0.42197445 |
| 94 | MP0003718_maternal_effect | 0.41128032 |
| 95 | MP0000566_synostosis | 0.41092553 |
| 96 | MP0005166_decreased_susceptibility_to | 0.38957011 |
| 97 | MP0003075_altered_response_to | 0.37595082 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.36855126 |
| 99 | MP0004885_abnormal_endolymph | 0.35700608 |
| 100 | MP0008874_decreased_physiological_sensi | 0.35608083 |
| 101 | MP0009672_abnormal_birth_weight | 0.33703766 |
| 102 | MP0004147_increased_porphyrin_level | 0.32840706 |
| 103 | MP0006082_CNS_inflammation | 0.31232694 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.30332142 |
| 105 | MP0008873_increased_physiological_sensi | 0.29403186 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.29023168 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.28372669 |
| 108 | MP0002090_abnormal_vision | 0.27979059 |
| 109 | MP0005448_abnormal_energy_balance | 0.27641028 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.25903436 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.25850923 |
| 112 | MP0000639_abnormal_adrenal_gland | 0.25805428 |
| 113 | MP0008872_abnormal_physiological_respon | 0.25499034 |
| 114 | MP0009115_abnormal_fat_cell | 0.25389609 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.25313204 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.25111019 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.24492436 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.24335128 |
| 119 | MP0005197_abnormal_uvea_morphology | 0.24045347 |
| 120 | MP0002970_abnormal_white_adipose | 0.23559799 |
| 121 | MP0001851_eye_inflammation | 0.22452339 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.20473957 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.19615791 |
| 124 | MP0000920_abnormal_myelination | 0.18658854 |
| 125 | MP0003632_abnormal_nervous_system | 0.18311526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.11515328 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.75162329 |
| 3 | Hyperglycinuria (HP:0003108) | 5.31233514 |
| 4 | Gout (HP:0001997) | 5.26232425 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.22105878 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.16509779 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.95120510 |
| 8 | Glomerulonephritis (HP:0000099) | 4.93663540 |
| 9 | Xanthomatosis (HP:0000991) | 4.88872328 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.84850729 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.84850729 |
| 12 | Ketosis (HP:0001946) | 4.74231882 |
| 13 | Hyperglycinemia (HP:0002154) | 4.58615999 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.41628043 |
| 15 | Hyperammonemia (HP:0001987) | 4.34720849 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.32769673 |
| 17 | Ketoacidosis (HP:0001993) | 4.25667126 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 4.23679619 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.17703925 |
| 20 | Complement deficiency (HP:0004431) | 4.17421124 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 4.16583371 |
| 22 | Increased purine levels (HP:0004368) | 4.00316656 |
| 23 | Hyperuricemia (HP:0002149) | 4.00316656 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.95116801 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92754012 |
| 26 | Delayed CNS myelination (HP:0002188) | 3.88404708 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.82411650 |
| 28 | Abnormality of nucleobase metabolism (HP:0010932) | 3.73983180 |
| 29 | Joint hemorrhage (HP:0005261) | 3.73263452 |
| 30 | Proximal tubulopathy (HP:0000114) | 3.70153977 |
| 31 | Nephritis (HP:0000123) | 3.68610112 |
| 32 | Hypokalemic alkalosis (HP:0001949) | 3.45813525 |
| 33 | Metabolic alkalosis (HP:0200114) | 3.44805873 |
| 34 | Hypomagnesemia (HP:0002917) | 3.44002179 |
| 35 | Fat malabsorption (HP:0002630) | 3.42526343 |
| 36 | Alkalosis (HP:0001948) | 3.39299529 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 3.38277110 |
| 38 | Increased circulating renin level (HP:0000848) | 3.37815405 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.35533450 |
| 40 | Hypolipoproteinemia (HP:0010981) | 3.18471357 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15325033 |
| 42 | Metabolic acidosis (HP:0001942) | 3.15021498 |
| 43 | Abnormal urine output (HP:0012590) | 3.13038275 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 3.09471383 |
| 45 | Hemorrhage of the eye (HP:0011885) | 3.05580512 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 3.04920959 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04920959 |
| 48 | Generalized aminoaciduria (HP:0002909) | 3.04792808 |
| 49 | Epidermoid cyst (HP:0200040) | 3.02175378 |
| 50 | Menorrhagia (HP:0000132) | 3.01258728 |
| 51 | Polyuria (HP:0000103) | 3.01222421 |
| 52 | Gingival bleeding (HP:0000225) | 2.98883776 |
| 53 | Abnormality of complement system (HP:0005339) | 2.96127079 |
| 54 | Abnormality of chloride homeostasis (HP:0011422) | 2.92545542 |
| 55 | Vascular calcification (HP:0004934) | 2.91777176 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.91028002 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.88782798 |
| 58 | Osteomalacia (HP:0002749) | 2.87376090 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.87066770 |
| 60 | Abnormality of magnesium homeostasis (HP:0004921) | 2.87055713 |
| 61 | Lethargy (HP:0001254) | 2.84946744 |
| 62 | Abnormality of renal excretion (HP:0011036) | 2.82908828 |
| 63 | Hypoalphalipoproteinemia (HP:0003233) | 2.79732603 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.76206941 |
| 65 | Purpura (HP:0000979) | 2.72928846 |
| 66 | Malnutrition (HP:0004395) | 2.69988959 |
| 67 | Abnormality of the intrinsic pathway (HP:0010989) | 2.69722848 |
| 68 | Steatorrhea (HP:0002570) | 2.67409852 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.66600805 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.62553850 |
| 71 | Vomiting (HP:0002013) | 2.62183663 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.62099685 |
| 73 | Glycosuria (HP:0003076) | 2.62099685 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.61747526 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.58443431 |
| 76 | Neonatal onset (HP:0003623) | 2.57708022 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.56282363 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.54990204 |
| 79 | Cholecystitis (HP:0001082) | 2.54990204 |
| 80 | Enlarged kidneys (HP:0000105) | 2.53761335 |
| 81 | Thrombophlebitis (HP:0004418) | 2.52257733 |
| 82 | Hydroxyprolinuria (HP:0003080) | 2.51932639 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.51932639 |
| 84 | Pulmonary embolism (HP:0002204) | 2.48488210 |
| 85 | Irritability (HP:0000737) | 2.45599487 |
| 86 | Tetany (HP:0001281) | 2.38262178 |
| 87 | Cerebral edema (HP:0002181) | 2.38104924 |
| 88 | Rickets (HP:0002748) | 2.37711744 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.37340702 |
| 90 | Polydipsia (HP:0001959) | 2.37340702 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.35137735 |
| 92 | Nephrolithiasis (HP:0000787) | 2.34258623 |
| 93 | Spastic diplegia (HP:0001264) | 2.32956560 |
| 94 | Renal tubular acidosis (HP:0001947) | 2.32583009 |
| 95 | Sensorimotor neuropathy (HP:0007141) | 2.31255016 |
| 96 | Fair hair (HP:0002286) | 2.30751602 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 2.29136439 |
| 98 | Renal salt wasting (HP:0000127) | 2.26621818 |
| 99 | Hypercholesterolemia (HP:0003124) | 2.23443804 |
| 100 | Late onset (HP:0003584) | 2.20859819 |
| 101 | Confusion (HP:0001289) | 2.20817088 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17204353 |
| 103 | Hyperaldosteronism (HP:0000859) | 2.14778843 |
| 104 | Cholelithiasis (HP:0001081) | 2.14338640 |
| 105 | Arthropathy (HP:0003040) | 2.14135153 |
| 106 | Hyperphosphaturia (HP:0003109) | 2.12942750 |
| 107 | Myocardial infarction (HP:0001658) | 2.10456856 |
| 108 | Spontaneous abortion (HP:0005268) | 2.03532767 |
| 109 | Neonatal hypoglycemia (HP:0001998) | 2.03022188 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 2.02945067 |
| 111 | Pancreatitis (HP:0001733) | 2.01949671 |
| 112 | Mitral stenosis (HP:0001718) | 2.01823127 |
| 113 | Bifid scrotum (HP:0000048) | 2.01054122 |
| 114 | Abnormality of renin-angiotensin system (HP:0000847) | 2.00689049 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97581499 |
| 116 | Gangrene (HP:0100758) | 1.97020710 |
| 117 | Elevated alkaline phosphatase (HP:0003155) | 1.95030650 |
| 118 | Hypophosphatemic rickets (HP:0004912) | 1.93756112 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.93076235 |
| 120 | Nausea (HP:0002018) | 1.93054028 |
| 121 | Hypoglycemic seizures (HP:0002173) | 1.92054597 |
| 122 | Hypophosphatemia (HP:0002148) | 1.91283677 |
| 123 | Opisthotonus (HP:0002179) | 1.90597238 |
| 124 | Hypochromic microcytic anemia (HP:0004840) | 1.90048759 |
| 125 | Increased serum ferritin (HP:0003281) | 1.85761415 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.78777981 |
| 127 | Poikilocytosis (HP:0004447) | 1.78186462 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.77998726 |
| 129 | Atrioventricular block (HP:0001678) | 1.76415778 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.76348386 |
| 131 | Epistaxis (HP:0000421) | 1.73924538 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 1.69663908 |
| 133 | Bile duct proliferation (HP:0001408) | 1.69663908 |
| 134 | Joint swelling (HP:0001386) | 1.65929733 |
| 135 | Impaired platelet aggregation (HP:0003540) | 1.65820612 |
| 136 | Abnormal platelet function (HP:0011869) | 1.65820612 |
| 137 | Abnormal platelet volume (HP:0011876) | 1.61011714 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.60699764 |
| 139 | Reticulocytosis (HP:0001923) | 1.58466965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 6.78261118 |
| 2 | BCKDK | 6.51845634 |
| 3 | OXSR1 | 4.59439056 |
| 4 | WNK4 | 4.40410328 |
| 5 | FGFR4 | 3.76017213 |
| 6 | ERN1 | 3.43761339 |
| 7 | SIK1 | 2.65439196 |
| 8 | STK38L | 2.35653963 |
| 9 | PRPF4B | 2.33909517 |
| 10 | PIK3CA | 2.24103366 |
| 11 | ERBB4 | 2.08211767 |
| 12 | MST1R | 1.96548689 |
| 13 | INSRR | 1.83135834 |
| 14 | NTRK3 | 1.78945656 |
| 15 | TAOK3 | 1.67847416 |
| 16 | PDK3 | 1.49444712 |
| 17 | PDK4 | 1.49444712 |
| 18 | MAPK11 | 1.49119652 |
| 19 | NEK1 | 1.47092485 |
| 20 | MAP2K4 | 1.46374589 |
| 21 | PINK1 | 1.45003283 |
| 22 | STK39 | 1.39728696 |
| 23 | SGK223 | 1.39439919 |
| 24 | SGK494 | 1.39439919 |
| 25 | TRIB3 | 1.34872938 |
| 26 | GRK6 | 1.25895051 |
| 27 | ABL2 | 1.17637087 |
| 28 | PTK6 | 1.15377379 |
| 29 | MAP3K7 | 1.14675885 |
| 30 | PIK3CG | 1.09687561 |
| 31 | CSF1R | 1.09389297 |
| 32 | LATS1 | 1.08478126 |
| 33 | SGK3 | 1.05756026 |
| 34 | PDK2 | 1.04356428 |
| 35 | PKN2 | 1.03321824 |
| 36 | SGK2 | 1.01710087 |
| 37 | TNK2 | 1.00626738 |
| 38 | MAP3K2 | 1.00306696 |
| 39 | EPHB1 | 0.95967519 |
| 40 | PRKG1 | 0.94604698 |
| 41 | JAK2 | 0.93651428 |
| 42 | TYK2 | 0.93616718 |
| 43 | DAPK2 | 0.91786982 |
| 44 | TIE1 | 0.91612470 |
| 45 | NLK | 0.89601673 |
| 46 | STK38 | 0.89337162 |
| 47 | PRKAA2 | 0.86201900 |
| 48 | GSK3A | 0.84129373 |
| 49 | CSNK1D | 0.83287747 |
| 50 | MAP3K3 | 0.81481023 |
| 51 | NEK9 | 0.81056068 |
| 52 | RET | 0.80212200 |
| 53 | FLT3 | 0.79455422 |
| 54 | MYLK | 0.79048542 |
| 55 | MAP3K14 | 0.78659366 |
| 56 | MAP3K12 | 0.78374555 |
| 57 | PRKCZ | 0.78132047 |
| 58 | PRKAA1 | 0.77024224 |
| 59 | DYRK1B | 0.76177987 |
| 60 | MET | 0.75641689 |
| 61 | TAOK2 | 0.74770701 |
| 62 | FRK | 0.74409929 |
| 63 | MAP2K3 | 0.74167860 |
| 64 | PTK2 | 0.70232418 |
| 65 | KDR | 0.69140928 |
| 66 | MUSK | 0.67610000 |
| 67 | MAP3K11 | 0.66786794 |
| 68 | PRKCB | 0.64888773 |
| 69 | STK16 | 0.64417490 |
| 70 | MAPK15 | 0.63993171 |
| 71 | ZAP70 | 0.61571874 |
| 72 | MAP3K1 | 0.61054533 |
| 73 | FGFR2 | 0.60914489 |
| 74 | CAMKK1 | 0.60897636 |
| 75 | ERBB2 | 0.60842910 |
| 76 | PDPK1 | 0.59616569 |
| 77 | PRKACG | 0.59467135 |
| 78 | RPS6KA3 | 0.58110833 |
| 79 | CAMKK2 | 0.57808984 |
| 80 | CDK4 | 0.57538193 |
| 81 | LRRK2 | 0.55984211 |
| 82 | TGFBR2 | 0.54204947 |
| 83 | MAPKAPK3 | 0.53903132 |
| 84 | WNK1 | 0.53605485 |
| 85 | MAPK12 | 0.53578605 |
| 86 | SCYL2 | 0.52367704 |
| 87 | MAPK4 | 0.51750541 |
| 88 | RIPK1 | 0.51237248 |
| 89 | MAP3K6 | 0.50418345 |
| 90 | TBK1 | 0.49512960 |
| 91 | PRKACB | 0.47787484 |
| 92 | IRAK3 | 0.46459142 |
| 93 | CSNK2A1 | 0.45335955 |
| 94 | JAK1 | 0.45252064 |
| 95 | CAMK2G | 0.45012207 |
| 96 | MAP3K5 | 0.44367233 |
| 97 | SRC | 0.43782069 |
| 98 | CSNK2A2 | 0.41020165 |
| 99 | PIM2 | 0.40998812 |
| 100 | MAP3K10 | 0.40261713 |
| 101 | BLK | 0.39658634 |
| 102 | MAP2K6 | 0.39578001 |
| 103 | CSNK1E | 0.39433924 |
| 104 | EIF2AK1 | 0.38146672 |
| 105 | EPHA4 | 0.37836339 |
| 106 | CDK6 | 0.37636200 |
| 107 | CSK | 0.36365086 |
| 108 | PDK1 | 0.35277920 |
| 109 | PAK3 | 0.32906336 |
| 110 | PRKCQ | 0.31623806 |
| 111 | IRAK2 | 0.30523215 |
| 112 | MAPK3 | 0.30507525 |
| 113 | MAP3K13 | 0.28702049 |
| 114 | CSNK1A1 | 0.28254834 |
| 115 | SGK1 | 0.27564321 |
| 116 | IGF1R | 0.26878630 |
| 117 | EPHA3 | 0.26668682 |
| 118 | FER | 0.25585884 |
| 119 | PRKCG | 0.25487016 |
| 120 | MTOR | 0.25282383 |
| 121 | CAMK4 | 0.24942521 |
| 122 | PRKCD | 0.24914137 |
| 123 | PRKCA | 0.24607919 |
| 124 | IRAK1 | 0.22546465 |
| 125 | PKN1 | 0.22134554 |
| 126 | MAP2K1 | 0.21250363 |
| 127 | BMX | 0.21196259 |
| 128 | EGFR | 0.19866699 |
| 129 | MAPK7 | 0.19718908 |
| 130 | FGFR3 | 0.17673875 |
| 131 | ICK | 0.16591467 |
| 132 | CSNK1G1 | 0.16165600 |
| 133 | PRKCH | 0.15762792 |
| 134 | PRKACA | 0.15331504 |
| 135 | MAP2K2 | 0.14807201 |
| 136 | CAMK1D | 0.14201753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90333680 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23862195 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.11060293 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97116893 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.91206085 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.84277015 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.83789512 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.82750472 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76123533 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56051820 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53072582 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.47991862 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.45589867 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.42339135 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.39333540 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38145238 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35382563 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10699866 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.10070082 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87482851 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85234639 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79669177 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75226730 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71576566 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65870074 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65136425 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61850226 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60768786 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60651289 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59415062 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58485585 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55647077 |
| 33 | * Bile secretion_Homo sapiens_hsa04976 | 1.55338764 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54979710 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52767727 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44119751 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.40796725 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38800668 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35840021 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32209451 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30749028 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28712987 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22929657 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22497727 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21247409 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19790505 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16335235 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15029739 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11161895 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08072077 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 1.04551174 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04293480 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03223898 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94196052 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90349479 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.89175113 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84304130 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79363330 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76555845 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76398125 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74954802 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73136516 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69785854 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61445995 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59510205 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53165807 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50938074 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.33954284 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.24890375 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23333703 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20740251 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19786326 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18206983 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.17739674 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15623505 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12818024 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09788067 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09582265 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.09416574 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.08957350 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.08372642 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.06732496 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05036066 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04201277 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02773131 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01891110 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.01663094 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01466866 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01165163 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.00791538 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2536930 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2223864 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1999538 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1815994 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1788637 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1737377 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | -0.1602085 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1551761 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1546048 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1545873 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1488665 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | -0.1299845 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1246250 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1203386 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0806427 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0750121 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0522864 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0388669 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0320018 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0196136 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0115695 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0086450 |

